Vaxxinity Financial Statements From 2010 to 2025
Vaxxinity financial statements provide useful quarterly and yearly information to potential Vaxxinity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Vaxxinity financial statements helps investors assess Vaxxinity's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Vaxxinity's valuation are summarized below:Vaxxinity does not presently have any fundamental trend indicators for analysis.
This module can also supplement various Vaxxinity Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Check Vaxxinity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxxinity's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vaxxinity financial statements analysis is a perfect complement when working with Vaxxinity Valuation or Volatility modules.
Vaxxinity |
Vaxxinity Company Return On Equity Analysis
Vaxxinity's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vaxxinity Return On Equity | -1.51 |
Most of Vaxxinity's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxxinity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Vaxxinity has a Return On Equity of -1.5065. This is 93.72% lower than that of the Biotechnology sector and 95.87% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Vaxxinity Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vaxxinity's current stock value. Our valuation model uses many indicators to compare Vaxxinity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vaxxinity competition to find correlations between indicators driving Vaxxinity's intrinsic value. More Info.Vaxxinity is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vaxxinity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vaxxinity's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |